Cancer glossary
Hand-foot syndrome: red, sore palms and soles during treatment
Hand-foot syndrome is a common side effect of capecitabine, fluorouracil and some targeted drugs. What it looks like, how to protect your skin and when to call your doctor.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
Hand-foot syndrome (palmar-plantar erythrodysesthesia) is redness, swelling, burning and peeling of the skin of the palms and soles. It most often occurs with capecitabine, fluorouracil and liposomal doxorubicin, and with targeted drugs such as sunitinib, sorafenib, regorafenib, axitinib and others.
How it appears in a discharge summary
- ‘Hand-foot syndrome grade 1’ — redness, numbness, no pain.
- ‘Grade 2’ — pain, swelling, peeling; it gets in the way of daily tasks.
- ‘Grade 3’ — blisters, cracks, ulcers, severe pain; unable to walk or hold things.
Grades are assessed on the CTCAE scale.
What it means
According to the American Cancer Society, the exact cause is unknown. It is thought that pressure from walking and gripping ‘squeezes’ the drug out of the tiny blood vessels of the palms and soles, and it irritates the tissue. That is why friction, pressure and heat make the syndrome worse.
What helps:
- avoiding hot water, long baths and saunas;
- avoiding pressure on palms and soles — no long walks, heavy manual work or tight shoes;
- loose soft shoes and cotton socks;
- moisturizing the skin without rubbing;
- cool compresses for burning;
- not popping blisters — if one bursts, tell your doctor.
Does it affect treatment
At grades 2–3 the doctor usually pauses treatment and lowers the dose. This does not harm the outcome the way stopping treatment early because of severe complications would.
Questions to ask your doctor
- Which cream should I use from day one?
- At what signs should I stop the tablets and call?
- Can I keep working if my job involves using my hands or walking?
Sources
- Hand-Foot Syndrome — American Cancer Society
- Capecitabine — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
